You are here

Takeda

After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine

Pharmaforum

Mon, 05/24/21 - 10:55 am

clinical trials

FDA Accepts NDA for Takeda’s Maribavir

BioSpace

Sun, 05/23/21 - 02:56 pm

post-transplant cytomegalovirus

Takeda tees up priority review for storied CMV drug from its $62B Shire buyout

Endpoints

Fri, 05/21/21 - 10:51 am

Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer

Endpoints

Wed, 05/19/21 - 11:14 pm

non-small cell lung cancer

Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict

Fierce Pharma

Wed, 05/19/21 - 11:05 pm

With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO

Fierce Pharma

Tue, 05/11/21 - 11:15 am

The retreat of corporate venture funding?

EP Vantage

Fri, 04/23/21 - 11:02 am

venture funding

venture capital

Boehringer Ingelheim

Bristol Myers Squibb

2,400 people remain without rare disease drug as Takeda manufacturing woes continue

Endpoints

Mon, 04/5/21 - 02:55 pm

hypoparathyroidism

drug manufacturing

Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test

BioPharma Dive

Mon, 04/5/21 - 02:43 pm

Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m

Pharmaceutical Business Review

Thu, 04/1/21 - 10:50 am

Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push

Fierce Pharma

Wed, 03/31/21 - 10:49 am

eosinophilic esophagitis

Takeda taps BridGene to pursue hard-to-drug neurodegenerative disease targets

Fierce Biotech

Tue, 03/30/21 - 11:38 am

BridGene Biosciences

small molecule drugs

neurodegenerative disease

Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases

NASDAQ

Thu, 03/18/21 - 11:06 am

drug development

Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies

Endpoints

Mon, 03/15/21 - 11:10 am

Vivek Ramaswamy

lipid nanoparticles

Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021

PR Newswire

Tue, 03/9/21 - 10:45 am

From partner to part of the family: Takeda pulls the trigger on Maverick buyout

Fierce Biotech

Tue, 03/9/21 - 10:32 am

Maverick Therapeutics

Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Fierce Pharma

Thu, 03/4/21 - 11:21 pm

non-small cell lung cancer

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

Fierce Pharma

Wed, 03/3/21 - 12:01 am

A closely watched schizophrenia drug fails key test

BioPharma Dive

Tue, 03/2/21 - 11:54 pm

clinical trials

Early Morphic data hint at a threat to Entyvio

EP Vantage

Mon, 03/1/21 - 11:47 pm

Morphic Therpeuitc

Pages